British Society for Antimicrobial Chemotherapy Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2002
NCT00128323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

gentian violet (genapax) (1 trial)

nystatin (mycostatin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 3)

Candidiasis, Oral (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2